China Pharma Holdings (CPHI) Raw Materials (2017 - 2024)

China Pharma Holdings has reported Raw Materials for 8 years, with the latest figure at $869820.0 in Q3 2024.

• For the quarter ending Q3 2024, Raw Materials fell 53.69% year-over-year to $869820.0; the trailing twelve-month figure through Sep 2024 stood at $869820.0 (down 53.69% YoY), and the FY2023 full-year result was $1.8 million, up 0.52% from the prior year.
• Raw Materials for Q3 2024 stood at $869820.0, down from $1.2 million in the prior quarter.
• The five-year high for Raw Materials was $2.2 million in Q1 2023, with the low at $869820.0 in Q3 2024.
• Historically, Raw Materials has averaged $1.8 million across 5 years, with a median of $1.8 million in 2021.
• Annual changes were most pronounced in 2023 — Raw Materials advanced 20.5% — and 2024, when it slumped 53.69%.
• China Pharma Holdings' Raw Materials stood at $2.1 million in 2020, then dropped by 11.63% to $1.8 million in 2021, then changed by 0.0% to $1.8 million in 2022, then gained by 0.52% to $1.8 million in 2023, then sank by 52.96% to $869820.0 in 2024.
• The last three Raw Materials figures came in at $869820.0 (Q3 2024), $1.2 million (Q2 2024), and $1.7 million (Q1 2024), per Business Quant data.